Abstract |
We demonstrate evidence supporting the efficacy of hydroxocobalamin in reducing vasopressor requirements for LVAD patients with refractory vasoplegia. Further study is needed to substantiate these findings and determine its optimal use in practice.
|
Authors | Brian Ayers, Katherine Wood, Jennifer Falvey, Wendy Bernstein, Igor Gosev |
Journal | Clinical case reports
(Clin Case Rep)
Vol. 8
Issue 9
Pg. 1722-1727
(Sep 2020)
ISSN: 2050-0904 [Print] England |
PMID | 32983485
(Publication Type: Case Reports)
|
Copyright | © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. |